Ken Griffin Fulgent Genetics, Inc. Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$19.6 - $25.06 $64,680 - $82,698	3,300 Added 41.25%	11,300 $245,000
Q2 2024 Aug 14, 2024	SELL	$19.09 - $22.57 $391,345 - $462,685	-20,500 Reduced 71.93%	8,000 $156,000
Q1 2024 May 15, 2024	SELL	$21.55 - $29.29 $1.02 Million - $1.39 Million	-47,400 Reduced 62.45%	28,500 $618,000
Q4 2023 Feb 14, 2024	SELL	$23.64 - $30.27 $572,088 - $732,534	-24,200 Reduced 24.18%	75,900 $2.19 Million
Q3 2023 Nov 14, 2023	BUY	$26.74 - $40.81 $917,182 - $1.4 Million	34,300 Added 52.13%	100,100 $2.68 Million
Q2 2023 Aug 14, 2023	SELL	$28.52 - $40.7 $99,820 - $142,450	-3,500 Reduced 5.05%	65,800 $2.44 Million
Q1 2023 May 15, 2023	BUY	$29.39 - $36.27 $17,634 - $21,762	600 Added 0.87%	69,300 $2.16 Million
Q4 2022 Feb 14, 2023	BUY	$29.23 - $40.28 $415,066 - $571,976	14,200 Added 26.06%	68,700 $2.05 Million
Q3 2022 Nov 14, 2022	SELL	$37.92 - $63.74 $26,544 - $44,618	-700 Reduced 1.27%	54,500 $2.08 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $547M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.